Phase I Clinical Study of ZL-82 Tablets

Clinical trial NCT06055023 · COMPLETED

Trial details

NCT number: NCT06055023
Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis (RA)Inflammatory Bowel Disease - IBD1

Start date: 2023-04-09
Primary completion: 2024-01-28
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.